4//SEC Filing
Garanzini Michael 4
Accession 0001144204-17-060013
CIK 0001372514other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 6:53 PM ET
Size
5.6 KB
Accession
0001144204-17-060013
Insider Transaction Report
Form 4
Garanzini Michael
Chief Commercial Officer
Transactions
- Award
Stock Option (right to buy)
2017-11-17+85,000→ 85,000 totalExercise: $1.09Exp: 2027-11-17→ Common Stock (85,000 underlying)
Footnotes (1)
- [F1]The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on November 1, 2018, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years.
Documents
Issuer
EYEGATE PHARMACEUTICALS INC
CIK 0001372514
Entity typeother
Related Parties
1- filerCIK 0001722844
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 6:53 PM ET
- Size
- 5.6 KB